Sipuleucel - T is a vaccine for:
In prostate cancer, several immunologic strategies have been under clinical development. The most impoant of these include the sipuleucel-T(Provenge) autologous prostatic acid phosphates (PAP) - loaded dendritic cell vaccine, the GVAX allogeneic recombinant whole cell vaccine, and CTLA-4 inhibitory approaches.
RCC
Testicular tumor
Carcinoma prostate
Carcinoma bladder
Prostate and seminal vesicles